These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The role of glycogen synthase kinase 3 beta in neurodegenerative diseases. Yu H; Xiong M; Zhang Z Front Mol Neurosci; 2023; 16():1209703. PubMed ID: 37781096 [TBL] [Abstract][Full Text] [Related]
5. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia. Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810 [TBL] [Abstract][Full Text] [Related]
6. Vitamin E and neurodegenerative disorders associated with oxidative stress. Butterfield DA; Castegna A; Drake J; Scapagnini G; Calabrese V Nutr Neurosci; 2002 Sep; 5(4):229-39. PubMed ID: 12168685 [TBL] [Abstract][Full Text] [Related]
7. Drug repurposing for neurodegenerative diseases. Shukla H; John D; Banerjee S; Tiwari AK Prog Mol Biol Transl Sci; 2024; 207():249-319. PubMed ID: 38942541 [TBL] [Abstract][Full Text] [Related]
8. Involvement of Astrocytes and microRNA Dysregulation in Neurodegenerative Diseases: From Pathogenesis to Therapeutic Potential. Bai Y; Su X; Piao L; Jin Z; Jin R Front Mol Neurosci; 2021; 14():556215. PubMed ID: 33815055 [TBL] [Abstract][Full Text] [Related]
9. Biochemical and therapeutic effects of antioxidants in the treatment of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. Di Matteo V; Esposito E Curr Drug Targets CNS Neurol Disord; 2003 Apr; 2(2):95-107. PubMed ID: 12769802 [TBL] [Abstract][Full Text] [Related]
10. Oxidative Stress in Neurodegenerative Diseases. Niedzielska E; Smaga I; Gawlik M; Moniczewski A; Stankowicz P; Pera J; Filip M Mol Neurobiol; 2016 Aug; 53(6):4094-4125. PubMed ID: 26198567 [TBL] [Abstract][Full Text] [Related]
11. Biochemical and Molecular Pathways in Neurodegenerative Diseases: An Integrated View. Sanghai N; Tranmer GK Cells; 2023 Sep; 12(18):. PubMed ID: 37759540 [TBL] [Abstract][Full Text] [Related]
12. Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases. Konovalova J; Gerasymchuk D; Parkkinen I; Chmielarz P; Domanskyi A Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801298 [TBL] [Abstract][Full Text] [Related]
13. Do Post-Translational Modifications Influence Protein Aggregation in Neurodegenerative Diseases: A Systematic Review. Schaffert LN; Carter WG Brain Sci; 2020 Apr; 10(4):. PubMed ID: 32290481 [TBL] [Abstract][Full Text] [Related]
14. Molecular diagnostics of neurodegenerative disorders. Agrawal M; Biswas A Front Mol Biosci; 2015; 2():54. PubMed ID: 26442283 [TBL] [Abstract][Full Text] [Related]
15. Bioenergetic and oxidative stress in neurodegenerative diseases. Bowling AC; Beal MF Life Sci; 1995; 56(14):1151-71. PubMed ID: 7475893 [TBL] [Abstract][Full Text] [Related]
16. Prionoid Proteins in the Pathogenesis of Neurodegenerative Diseases. Wells C; Brennan SE; Keon M; Saksena NK Front Mol Neurosci; 2019; 12():271. PubMed ID: 31780895 [TBL] [Abstract][Full Text] [Related]
17. Roles of Long Non-coding RNAs in the Development of Aging-Related Neurodegenerative Diseases. Ni YQ; Xu H; Liu YS Front Mol Neurosci; 2022; 15():844193. PubMed ID: 35359573 [TBL] [Abstract][Full Text] [Related]
18. microRNAs and Neurodegenerative Diseases. Qiu L; Tan EK; Zeng L Adv Exp Med Biol; 2015; 888():85-105. PubMed ID: 26663180 [TBL] [Abstract][Full Text] [Related]
19. Long Noncoding RNAs in Neurodegenerative Diseases: Pathogenesis and Potential Implications as Clinical Biomarkers. Zhang M; He P; Bian Z Front Mol Neurosci; 2021; 14():685143. PubMed ID: 34421536 [TBL] [Abstract][Full Text] [Related]